{
    "data": [
        {
            "id": "6903f19aecb8a7000145d4c1",
            "title": "Here&#39;s How Much $1000 Invested In Palo Alto Networks 10 Years Ago Would Be Worth Today",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">Palo Alto Networks (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/PANW\" target=\"_blank\">PANW</a>) has outperformed the market over the past 10 years by 10.47% on an annualized basis producing an average annual return of 22.91%. Currently, Palo Alto Networks has a market capitalization of $147.12 billion. </p><!--/$--><!--$--><p class=\"block core-block\"><strong>Buying $1000 In PANW:</strong> If an investor had bought $1000 of PANW stock 10 years ago, it would be worth <strong>$7,828.91</strong> today based on a price of $217.35 for PANW at the time of writing.</p><!--/$--><!--$--><h3 class=\"block core-block\">Palo Alto Networks's Performance Over Last 10 Years</h3><!--/$--><!--$--><div class=\"sc-feVKPA LhjAx core-image flex items-center justify-center\"><span style=\"background:none;border:0;box-sizing:border-box;display:inline-block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:relative;max-width:100%\"><span style=\"background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;padding:0;width:initial;max-width:100%\"><img alt=\"\" aria-hidden=\"true\" src=\"data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iMTUwMCIgaGVpZ2h0PSI4MDAiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyIgdmVyc2lvbj0iMS4xIi8+\" style=\"background:none;border:0;display:block;height:initial;margin:0;max-width:100%;opacity:1;padding:0;width:initial\"/></span><img alt=\"\" decoding=\"async\" loading=\"lazy\" src=\"data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/><noscript><img alt=\"\" decoding=\"async\" fetchpriority=\"low\" loading=\"lazy\" sizes=\"(max-width: 800px) 1500px, (min-width: 800px) 1500px\" src=\"https://www.benzinga.com/files/images/story/2025/1761866139_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=3840\" srcset=\"https://www.benzinga.com/files/images/story/2025/1761866139_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1920 1x, https://www.benzinga.com/files/images/story/2025/1761866139_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=3840 2x\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/></noscript></span></div><!--/$--><!--$--><p class=\"block core-block\">Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p><!--/$--><!--$--><p class=\"block core-block\"><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p><!--/$--><!--$--><div class=\"sc-SfCGz ciVbir\"></div><!--/$--></div></div>",
            "image": "",
            "link": "https://www.benzinga.com/insights/news/25/10/48548065/heres-how-much-1000-invested-in-palo-alto-networks-10-years-ago-would-be-worth-today",
            "pub_date": "2025-10-31 07:15:42",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6903f518ecb8a7000145d4de",
            "title": "$100 Invested In Performance Food Group 10 Years Ago Would Be Worth This Much Today",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">Performance Food Group (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/PFGC\" target=\"_blank\">PFGC</a>) has outperformed the market over the past 10 years by 3.61% on an annualized basis producing an average annual return of 16.06%. Currently, Performance Food Group has a market capitalization of $15.16 billion. </p><!--/$--><!--$--><p class=\"block core-block\"><strong>Buying $100 In PFGC:</strong> If an investor had bought $100 of PFGC stock 10 years ago, it would be worth <strong>$422.45</strong> today based on a price of $96.66 for PFGC at the time of writing.</p><!--/$--><!--$--><h3 class=\"block core-block\">Performance Food Group's Performance Over Last 10 Years</h3><!--/$--><!--$--><div class=\"sc-feVKPA LhjAx core-image flex items-center justify-center\"><span style=\"background:none;border:0;box-sizing:border-box;display:inline-block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:relative;max-width:100%\"><span style=\"background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;padding:0;width:initial;max-width:100%\"><img alt=\"\" aria-hidden=\"true\" src=\"data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iMTUwMCIgaGVpZ2h0PSI4MDAiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyIgdmVyc2lvbj0iMS4xIi8+\" style=\"background:none;border:0;display:block;height:initial;margin:0;max-width:100%;opacity:1;padding:0;width:initial\"/></span><img alt=\"\" decoding=\"async\" loading=\"lazy\" src=\"data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/><noscript><img alt=\"\" decoding=\"async\" fetchpriority=\"low\" loading=\"lazy\" sizes=\"(max-width: 800px) 1500px, (min-width: 800px) 1500px\" src=\"https://www.benzinga.com/files/images/story/2025/1761867033_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=3840\" srcset=\"https://www.benzinga.com/files/images/story/2025/1761867033_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1920 1x, https://www.benzinga.com/files/images/story/2025/1761867033_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=3840 2x\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/></noscript></span></div><!--/$--><!--$--><p class=\"block core-block\">Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p><!--/$--><!--$--><p class=\"block core-block\"><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p><!--/$--><!--$--><div class=\"sc-bNqYHQ hvXQzJ\"></div><!--/$--></div></div>",
            "image": "",
            "link": "https://www.benzinga.com/insights/news/25/10/48548128/100-invested-in-performance-food-group-10-years-ago-would-be-worth-this-much-today",
            "pub_date": "2025-10-31 07:30:36",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6904105fecb8a7000145d7e1",
            "title": "Cathie Wood Just Dumped $7.4 Million Worth Of Palantir And AMD Shares — Here&#39;s What Ark Is Buying Instead",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">On Thursday, <strong>Cathie Wood</strong>-led <strong>Ark Invest</strong> made significant trades involving <strong>Palantir Technologies Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/PLTR\" target=\"_blank\">PLTR</a>), <strong>Advanced Micro Devices Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/AMD\" target=\"_blank\">AMD</a>) , <strong>Pacific Biosciences of California Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/PACB\" target=\"_blank\">PACB</a>), and <strong>DoorDash Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/DASH\" target=\"_blank\">DASH</a>).</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">The <strong>Palantir</strong> Trade</h2><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>ARK Space Exploration &amp; Innovation ETF</strong> (BATS:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/ARKX\" target=\"_blank\">ARKX</a>) executed a sale of 19,954 shares of Palantir on Thursday. <br/>The transaction, valued at approximately $3.9 million based on the closing price of $194.55, comes amid the <strong>Alex Karp</strong>-led company’s expanding role in AI-driven technologies. </p><!--/$--><!--$--><p class=\"block core-block\">The company <a href=\"https://www.benzinga.com/markets/tech/25/10/48439748/palantirs-ai-in-the-sky-the-data-driven-future-of-drones\" target=\"_blank\">recently collaborated with drone firms</a> to enhance AI-powered flight and analytics, marking a significant step in the data-driven future of aerial technology.</p><!--/$--><!--$--><p class=\"block core-block\">Ark has been on a Palantir selling spree this week, <a href=\"https://www.benzinga.com/news/25/10/48483413/cathie-wood-just-dumped-more-palantir-shares-despite-holy-grail-ai-deal-heres-what-ark-bought-instead\" target=\"_blank\">unloading $4.1 million worth of shares</a> on Tuesday after selling another $2.63 million on Monday.</p><!--/$--><!--$--><div class=\"sc-fzzUx jSgJNL\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">The AMD Trade</h2><!--/$--><!--$--><p class=\"block core-block\">On the same day, <strong>ARK Autonomous Technology &amp; Robotics ETF</strong> (BATS:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/ARKQ\" target=\"_blank\">ARKQ</a>) sold 13,651 AMD shares amounting to approximately $3.5 million at the closing price of $254.84. </p><!--/$--><!--$--><p class=\"block core-block\">This move follows <a href=\"https://www.benzinga.com/markets/tech/25/10/48443591/us-taps-amd-for-supercomputers-that-could-change-energy-and-medicine-forever\" target=\"_blank\">AMD’s recent $1 billion partnership</a> with the U.S. government to develop supercomputers. The collaboration aims to bolster America’s leadership in high-performance computing, with potential impacts on energy, medicine, and national security.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">The <strong>Pacific Biosciences of California</strong> Trade</h2><!--/$--><!--$--><p class=\"block core-block\"><strong>ARK Innovation ETF</strong> (BATS:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/ARKK\" target=\"_blank\">ARKK</a>) acquired 633,420 shares of Pacific Biosciences of California on Thursday, valued at approximately $1.23 million at the closing price of $1.94. </p><!--/$--><!--$--><p class=\"block core-block\">This purchase aligns with anticipation surrounding Pacific Biosciences’ upcoming financial results, expected to be released on Nov. 5. Investors are keenly watching for insights into the company’s performance and future prospects.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">The DoorDash Trade</h2><!--/$--><!--$--><p class=\"block core-block\">Ark’s <strong>ARKX</strong> ETF also bought 2,045 shares of DoorDash, totaling roughly $519,573 at the closing price of $254.07. </p><!--/$--><!--$--><p class=\"block core-block\">This acquisition follows analyst expectations that DoorDash <a href=\"https://www.benzinga.com/analyst-stock-ratings/reiteration/25/10/48306965/doordash-expected-to-beat-q3-targets-raise-outlook-after-deliveroo-deal\" target=\"_blank\">may exceed third-quarter targets</a> and raise its outlook post-<strong>Deliveroo</strong> acquisition. The company is projected to achieve the high end of its gross merchandise value guidance. The earnings are expected on Nov. 5.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Other Key Trades</h2><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li>Sold 476,280 shares of <strong>Iridium Communications Inc. </strong>(IRDM) from <strong>ARKK</strong> ETF.</li>\n<li>Bought 8,853 shares of <strong>Intellia Therapeutics Inc.</strong> (NTLA) via <strong>ARKG</strong> ETF.</li>\n<li>Bought 7,525 shares of <strong>Deere &amp; Co</strong>. (DE) through <strong>ARKQ</strong> ETF and 5,010 shares via <strong>ARKX</strong>.</li>\n<li>Bought 1,196 shares of <strong>Synopsys Inc.</strong> (SNPS) in <strong>ARKX</strong> ETF.</li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><strong>Benzinga’s Edge Stock Rankings</strong> indicate AMD has Value in the 4th percentile. <a href=\"https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound\" target=\"_blank\">Here is how the stock measures up</a> to other AI plays.</p><!--/$--><!--$--><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48548973\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><a href=\"https://www.benzinga.com/crypto/cryptocurrency/25/10/48521417/mastercard-in-late-stage-talks-to-acquire-crypto-startup-zerohash-report\" target=\"_blank\"><strong>Mastercard In ‘Late-Stage Talks’ To Acquire Crypto Startup Zerohash: Report</strong></a></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo Courtesy: Ira Lichi On Shutterstock.com</em></p><!--/$--><!--$--><p class=\"block core-block\">This story was generated using <a href=\"https://www.benzinga.com/author/benzinga-neuro\" target=\"_blank\">Benzinga Neuro</a> and edited by <u><a href=\"https://www.benzinga.com/author/shivdeep-dhaliwal\" rel=\"noreferrer noopener\" target=\"_blank\">Shivdeep Dhaliwal</a></u></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/Russia-Moscow-24-06-2021-Logo-Of-Financi.jpeg",
            "link": "https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/10/48548973/cathie-wood-just-dumped-7-4-million-worth-of-palantir-and-amd-shares-heres-what-ark-is-buying-instead",
            "pub_date": "2025-10-31 09:26:59",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6903f89fecb8a7000145d55f",
            "title": "Here&#39;s How Much You Would Have Made Owning Arch Capital Group Stock In The Last 15 Years",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">Arch Capital Group (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/ACGL\" target=\"_blank\">ACGL</a>) has outperformed the market over the past 15 years by 3.4% on an annualized basis producing an average annual return of 15.49%. Currently, Arch Capital Group has a market capitalization of $31.42 billion. </p><!--/$--><!--$--><p class=\"block core-block\"><strong>Buying $1000 In ACGL:</strong> If an investor had bought $1000 of ACGL stock 15 years ago, it would be worth <strong>$8,653.42</strong> today based on a price of $85.55 for ACGL at the time of writing.</p><!--/$--><!--$--><h3 class=\"block core-block\">Arch Capital Group's Performance Over Last 15 Years</h3><!--/$--><!--$--><div class=\"sc-feVKPA LhjAx core-image flex items-center justify-center\"><span style=\"background:none;border:0;box-sizing:border-box;display:inline-block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:relative;max-width:100%\"><span style=\"background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;padding:0;width:initial;max-width:100%\"><img alt=\"\" aria-hidden=\"true\" src=\"data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iMTUwMCIgaGVpZ2h0PSI4MDAiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyIgdmVyc2lvbj0iMS4xIi8+\" style=\"background:none;border:0;display:block;height:initial;margin:0;max-width:100%;opacity:1;padding:0;width:initial\"/></span><img alt=\"\" decoding=\"async\" loading=\"lazy\" src=\"data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/><noscript><img alt=\"\" decoding=\"async\" fetchpriority=\"low\" loading=\"lazy\" sizes=\"(max-width: 800px) 1500px, (min-width: 800px) 1500px\" src=\"https://www.benzinga.com/files/images/story/2025/1761867936_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=3840\" srcset=\"https://www.benzinga.com/files/images/story/2025/1761867936_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1920 1x, https://www.benzinga.com/files/images/story/2025/1761867936_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=3840 2x\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/></noscript></span></div><!--/$--><!--$--><p class=\"block core-block\">Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p><!--/$--><!--$--><p class=\"block core-block\"><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p><!--/$--><!--$--><div class=\"sc-bNqYHQ hvXQzJ\"></div><!--/$--></div></div>",
            "image": "",
            "link": "https://www.benzinga.com/insights/news/25/10/48548275/heres-how-much-you-would-have-made-owning-arch-capital-group-stock-in-the-last-15-years",
            "pub_date": "2025-10-31 07:45:39",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6903ee0fecb8a7000145d422",
            "title": "Here&#39;s How Much $100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth Today",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">Vertex Pharmaceuticals (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/VRTX\" target=\"_blank\">VRTX</a>) has outperformed the market over the past 15 years by 5.91% on an annualized basis producing an average annual return of 18.0%. Currently, Vertex Pharmaceuticals has a market capitalization of $107.16 billion. </p><!--/$--><!--$--><p class=\"block core-block\"><strong>Buying $100 In VRTX:</strong> If an investor had bought $100 of VRTX stock 15 years ago, it would be worth <strong>$1,207.62</strong> today based on a price of $417.95 for VRTX at the time of writing.</p><!--/$--><!--$--><h3 class=\"block core-block\">Vertex Pharmaceuticals's Performance Over Last 15 Years</h3><!--/$--><!--$--><div class=\"sc-feVKPA LhjAx core-image flex items-center justify-center\"><span style=\"background:none;border:0;box-sizing:border-box;display:inline-block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:relative;max-width:100%\"><span style=\"background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;padding:0;width:initial;max-width:100%\"><img alt=\"\" aria-hidden=\"true\" src=\"data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iMTUwMCIgaGVpZ2h0PSI4MDAiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyIgdmVyc2lvbj0iMS4xIi8+\" style=\"background:none;border:0;display:block;height:initial;margin:0;max-width:100%;opacity:1;padding:0;width:initial\"/></span><img alt=\"\" decoding=\"async\" loading=\"lazy\" src=\"data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/><noscript><img alt=\"\" decoding=\"async\" fetchpriority=\"low\" loading=\"lazy\" sizes=\"(max-width: 800px) 1500px, (min-width: 800px) 1500px\" src=\"https://www.benzinga.com/files/images/story/2025/1761865232_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=3840\" srcset=\"https://www.benzinga.com/files/images/story/2025/1761865232_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1920 1x, https://www.benzinga.com/files/images/story/2025/1761865232_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=3840 2x\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/></noscript></span></div><!--/$--><!--$--><p class=\"block core-block\">Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p><!--/$--><!--$--><p class=\"block core-block\"><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p><!--/$--><!--$--><div class=\"sc-eQzVdq kfhAgV\"></div><!--/$--></div></div>",
            "image": "",
            "link": "https://www.benzinga.com/insights/news/25/10/48547844/heres-how-much-100-invested-in-vertex-pharmaceuticals-15-years-ago-would-be-worth-today",
            "pub_date": "2025-10-31 07:00:35",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}